A-V Tumor immunology Flashcards
(48 cards)
Metastasis
Spread of cancerous cells through lymph fluid or blood.
Neoantigens
Tumor antigens that are self-antigens with mutations and are recognized as foreign by the immune system.
CD8+ T-cells (in tumor immunity)
Recognize and kill tumor cells using perforin and granzyme cytotoxicity.
NK Cells (in tumor immunity)
Recognize and kill tumor cells via missing self-recognition (lack of MHC Class I), ADCC (Antibody-Dependent Cell-mediated Cytotoxicity) through FcγRIII binding to IgG antibodies and release of perforin, and FasL binding to Fas on tumor cells.
Macrophages (in tumor immunity)
Can kill tumor cells through ADCC, release lysosomal enzymes and ROS, and use TNF to induce thrombosis in tumor blood vessels.
CD4+ Th cells (in tumor immunity
Primarily involved in the activation of other effector cells, such as macrophages, to fight tumors.
Antibodies (in tumor immunity)
Can contribute to tumor destruction through complement activation and ADCC activation.
Tumor immune evasion
Mechanisms used by tumors to inhibit anti-tumor immune responses, such as antigen loss, failure to trigger APC co-stimulation, inhibition of MHC Class I expression, secretion of immunosuppressive cytokines (TGF-β, IL-10), induction of a physical barrier, and expression of PD-L1 and -L2.
PD-L1 and PD-L2 in tumor immunity
Inhibitory ligands upregulated on tumor cells and Antigen-Presenting Cells (APCs) that bind to PD-1/2 on effector T-cells, leading to inhibitory signaling and preventing an antitumor response.
Hot tumor
A tumor that is infiltrated by T-cells but exhibits immune escape, often through the expression of PD-L1.
Cold tumor
A tumor with no T-cell infiltration, leading to immune escape.
T-cell exclusion
A mechanism of immune escape where T-cells are unable to infiltrate the tumor, preventing killing of cancer cells.
Autoimmunity
A misdirected attack by the immune system on the body’s own tissues and organs.
Genetic risk factors for autoimmunity
Include MHC genes (both Class I and II associated), non-MHC genes like CTLA-4, AIRE, and FoxP3, as well as genes related to cytokines (e.g., IL-2/IL-2R) and complement components (e.g., C1q, C2, C4).
Enviromental risk factors for autoimmunity
Can include infections (e.g., Covid-19, Hepatitis C, EBV), traumatic insult (potentially introducing self-antigens), tissue inflammation, hormones, smoking, and the microbiome.
Immune tolerance in relation to autoimmunity
Autoimmunity represents a failure of immune tolerance, the mechanisms that prevent the immune system from attacking self-antigens.
Diabetes Type 1
An autoimmune disease involving the attack of β cells in the pancreas that produce insulin, leading to irreversible insulin deficiency.
Rheumatoid arthritis
A prevalent autoimmune disease characterized by the attack on peripheral joints, leading to inflammation, synovial membrane invasion, and eventual joint destruction. Specific autoantibodies like RF and ACPA are often present.
Multiple sclerosis
An autoimmune disease where the immune system attacks the central nervous system (CNS), specifically the myelin sheets that insulate nerve fibers, leading to neurological dysfunction.
Molecular mimicry (in autoimmunity)
A theory suggesting that microbial antigens can share structural similarities with self-antigens, potentially triggering an autoimmune response.
Type II hypersensitivity
A type of hypersensitivity reaction where antibodies bind to antigens on cells, leading to the activation of neutrophils and macrophages and cell destruction.
Type III hypersensitivity
A type of hypersensitivity reaction where large immune complexes form and deposit in tissues, causing neutrophil degranulation and tissue damage.
Treatment of autoimmune diseases
Primarily focuses on suppressing the immune response through various therapeutic targets. There is no cure, and treatment is typically lifelong.
What are tumor antigens also called, and what is their basic nature?
Tumor antigens are also called neoantigens, and they are essentially mutated self-antigens that are recognized as foreign by the immune system